Jay Schreiber Alain Pro Que... Net Worth

The estimated Net Worth of Jay Schreiber Alain Pro Que... is at least $7.64 Milion dollars as of 27 January 2016. Jay Que owns over 393,700 units of Agile Therapeutics Inc stock worth over $7,644,168 and over the last 10 years Jay sold AGRX stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Jay Que AGRX stock SEC Form 4 insiders trading

Jay has made over 4 trades of the Agile Therapeutics Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Jay bought 393,700 units of AGRX stock worth $2,499,995 on 27 January 2016.

The largest trade Jay's ever made was buying 1,120,833 units of Agile Therapeutics Inc stock on 29 May 2014 worth over $6,724,998. On average, Jay trades about 680,050 units every 152 days since 2014. As of 27 January 2016 Jay still owns at least 5,062,363 units of Agile Therapeutics Inc stock.

You can see the complete history of Jay Que stock trades at the bottom of the page.

Insiders trading at Agile Therapeutics Inc

Over the last 10 years, insiders at Agile Therapeutics Inc have traded over $2,369,944 worth of Agile Therapeutics Inc stock and bought 24,967,253 units worth $79,522,957 . The most active insiders traders include Advisors Llcperceptive Life..., Ab Investor a Capital Iii Llc Care Capita.... On average, Agile Therapeutics Inc executives and independent directors trade stock every 69 days with the average trade being worth of $1,032,678. The most recent stock trade was executed by Alfred Altomari on 26 August 2022, trading 50,000 units of AGRX stock currently worth $22,500.

What does Agile Therapeutics Inc do?

agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.

Complete history of Jay Que stock trades at Agile Therapeutics Inc

Agile Therapeutics Inc executives and stock owners

Agile Therapeutics Inc executives and other stock owners filed with the SEC include:

• Alfred Altomari,
  Chairman of the Board, Chief Executive Officer
• Alfred F. Altomari,
  Chairman & CEO
• Geoffrey Gilmore,
  Senior Vice President, General Counsel, Corporate Secretary
• Geoffrey P. Gilmore,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Dr. Paul Korner M.B.A., M.D.,
  Sr. VP & Chief Medical Officer
• Robert Conway,
  Senior Vice President and Chief Supply Chain Officer
• Dennis P. Reilly,
  Sr. VP & CFO
• John Hubbard,
  Independent Director
• James Tursi,
  Independent Director
• Seth Fischer,
  Lead Independent Director
• Ajit Shetty,
  Independent Director
• Sharon Barbari,
  Independent Director
• Sandra Carson,
  Director
• Paul Korner,
  Chief Medical Officer
• Dennis Reilly,
  Chief Financial Officer, Senior Vice President
• Dr. Kathryn MacFarlane Pharm.D.,
  Advisor
• Robert G. Conway M.E.,
  Sr. VP & Chief Supply Chain Officer
• Joseph D'Urso,
  Controller
• Dr. Paul Korner,
  Sr. VP & Chief Medical Officer
• Dr. Elizabeth Ijeoma Onyemelukwe Garner M.D., M.P.H.,
  Consultant
• Robert G. Conway,
  Sr. VP & Chief Supply Chain Officer
• Amy Welsh,
  VP of Marketing
• Matthew Riley,
  Head of Investor Relations & Corp. Communications
• Jason Butch,
  VP & Chief Accounting Officer
• Katie Mac Farlane,
  Chief Commercial Officer
• Scott M Coiante,
  Chief Financial Officer
• Karen Hong,
  Director
• Renee Selman,
  Chief Commercial Officer
• Jay Schreiber Alain Pro Que...,
  
• William Mckee,
  Director
• Abhijeet J Lele,
  Director
• Amy Welsh,
  Chief Commercial Officer
• Capital Iii Llc Care Capita...,
  
• Elizabeth Garner,
  Sr. VP & Chief Medical Officer
• Advisors Llcperceptive Life...,
  
• Ab Investor,
  10% owner
• Andrew N Schiff,
  Director
• Josephine Torrente,
  Director